Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.1 (
RNase
)
16,360
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A potential p120 GTPase-activating protein (RasGAP) effector,
G3BP
(RasGAP Src homology 3 [SH3] binding protein), was previously identified based on its ability to bind the SH3 domain of RasGAP. Here we show that
G3BP
colocalizes and physically interacts with RasGAP at the plasma membrane of serum-stimulated but not quiescent Chinese hamster lung fibroblasts. In quiescent cells,
G3BP
was hyperphosphorylated on serine residues, and this modification was essential for its activity. Indeed,
G3BP
harbors a phosphorylation-dependent
RNase
activity which specifically cleaves the 3'-untranslated region of human c-myc mRNA. The endoribonuclease activity of
G3BP
can initiate mRNA degradation and therefore represents a link between a RasGAP-mediated signaling pathway and RNA turnover.
...
PMID:A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stability. 963 80
We have found using differential display of mRNA that the growth factor heregulin beta 1 (HRG), a combinatorial ligand for human epidermal growth factor receptors (HERs), induced expression of
G3BP
, the Ras GTPase-activating protein SH3 domain-binding protein, in breast cancer cells.
G3BP
is a downstream effector protein of Ras signaling with ATP-dependent
RNase
and helicase activities, which may link Ras signaling with RNA turnover and cell cycle progression. In human breast cancer cells, HRG induced
G3BP
mRNA and protein expression. Up-regulation of
G3BP
was found in MCF7 breast cancer cells overexpressing HER2.
G3BP
was also overexpressed in human breast tumors in parallel with HER2 overexpression and in an estrogen-independent manner, suggesting a role for
G3BP
in cancer progression. In addition, HRG stimulation of breast cancer cells promoted phosphorylation of
G3BP
and increased the association of
G3BP
with GTPase-activating protein, both of which are essential for
G3BP
activity.
G3BP
ATPase activity was also significantly increased by HRG treatment. Furthermore, HRG treatment resulted in
G3BP
translocation to the nucleus and colocalization with acetylated histone H3, a hallmark of active transcription sites.
G3BP
induction, phosphorylation, ATPase activity, and relocalization after HRG treatment could all be blocked by pretreatment with the anti-receptor HER2 monoclonal antibody Herceptin (trastuzumab), which may suggest additional applications for this therapeutic antibody. These findings demonstrate for the first time the receptor-dependent regulation of
G3BP
, a downstream effector of Ras signaling, by HRG, a growth factor with diverse functions in breast cancer cells.
...
PMID:Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors. 1188 85
We report a novel function for the CD24 molecule in pancreatic cancer cells. Intracellular CD24 is associated with stress granules that contain specific mRNAs and RNA-binding proteins that regulate mRNA stability and translation. Intracellular CD24 in stress granules is associated with
G3BP
, a phosphorylation-dependent endoribonuclease. The vesicles in which the CD24/
G3BP
complex localizes are transported toward cell protrusions in migrating cells. We show that
G3BP
binds to and degrades Binder of Arl Two (BART) mRNA. BART was originally identified as a binding partner of ARL2, a small G-protein implicated as a regulator of microtubule dynamics and folding. Intracellular CD24 inhibits the specific endoribonuclease activity of
G3BP
toward BART mRNA in stress granules. We show that knockdown of CD24 increases retroperitoneal invasion and liver metastasis of pancreatic cancer cells in an orthotopic xenograft model, and that BART also prevents retroperitoneal invasion and liver metastasis of pancreatic cancer cells. Our results imply that surface CD24 may play a role in the inhibition of cell invasion and metastasis, and that intracellular CD24 inhibits invasiveness and metastasis through its influence on the posttranscriptional regulation of BART mRNA levels via
G3BP
RNase
activity.
...
PMID:Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP. 2126 61
Plakophilins 1 and 3 (PKP1/3) are members of the arm repeat family of catenin proteins and serve as structural components of desmosomes, which are important for cell-cell-adhesion. In addition, PKP1/3 occur as soluble proteins outside desmosomes, yet their role in the cytoplasm is not known. We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1,
G3BP
, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs. Moreover, we showed that the interaction of PKP1/3 with
G3BP
, PABPC1, and UPF1 but not with FXR1 was
RNase
sensitive. To address the cytoplasmic function of PKP1/3, we performed gain-and-loss-of-function studies. Both PKP1 and PKP3 knockdown cell lines showed reduced protein and mRNA levels for desmoplakin and PKP2. Whereas global rates of translation were unaffected, desmoplakin and PKP2 mRNA were destabilized. Furthermore, binding of PKP1/3 to FXR1 was RNA independent, and both PKP3 and FXR1 stabilized PKP2 mRNA. Our results demonstrate that cytoplasmic PKP1/3 are components of mRNA ribonucleoprotein particles and act as posttranscriptional regulators of gene expression.
...
PMID:Plakophilins 1 and 3 bind to FXR1 and thereby influence the mRNA stability of desmosomal proteins. 2522 33